Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Medicine price surveys, analyses and comparisons : evidence, methodology and guidance / / edited by Sabine Vogler
| Medicine price surveys, analyses and comparisons : evidence, methodology and guidance / / edited by Sabine Vogler |
| Pubbl/distr/stampa | London, England : , : Elsevier, , 2019 |
| Descrizione fisica | 1 online resource (490 pages) |
| Disciplina | 338.436151 |
| Soggetto topico |
Drugs - Prices
Pharmaceutical industry - Economic aspects Drugs - Economic aspects |
| ISBN | 0-12-813212-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover -- MEDICINE PRICE SURVEYS, ANALYSES, AND COMPARISONS -- MEDICINE PRICE SURVEYS, ANALYSES, AND COMPARISONS -- Copyright -- Dedication -- CONTENTS -- CONTRIBUTORS -- ACKNOWLEDGEMENTS -- 1 - Introduction -- LIST OF ABBREVIATIONS -- 1.1 BACKGROUND AND RATIONALE -- 1.2 AIM AND OUTLINE -- 1.3 METHODOLOGY -- 1.4 TARGET AUDIENCE -- REFERENCES -- 1 - Evidence - Findings of Medicine Price Studies -- 2 - International Comparison of Medicine Prices -- LIST OF ABBREVIATIONS -- 2.1 - Medicine Prices in European Countries -- LIST OF ABBREVIATIONS -- 2.1.1 INTRODUCTION -- 2.1.2 HIGH-COST MEDICINES -- 2.1.2.1 Oncology -- 2.1.2.2 Hepatitis C -- 2.1.2.3 Rare Diseases -- 2.1.2.4 Concordance of Prices With Purchasing Power -- 2.1.3 GENERIC MEDICINES -- 2.1.4 IMPACT OF POLICY MEASURES -- 2.1.4.1 External Price Referencing -- 2.1.4.1.1 Challenges Related to External Reference Pricing -- 2.1.4.2 Convergence of Medicine Prices Over Time -- 2.1.5 ACTUAL PRICES -- 2.1.6 FINAL REMARKS -- REFERENCES -- 2.2 - Medicine Prices in the United States and Canada -- LIST OF ABBREVIATIONS -- 2.2.1 CANADA -- 2.2.1.1 Policies -- 2.2.1.1.1 Federal Patented Drug Price Regulation -- 2.2.1.1.2 Drug Plan Reimbursement of Brand Drugs -- 2.2.1.1.3 Drug Plan Reimbursement of Generic Drugs -- 2.2.1.1.4 Biosimilars -- 2.2.1.2 Canada Drug Price Studies -- 2.2.1.2.1 Brand Drugs -- 2.2.1.2.2 Biologics -- 2.2.1.2.3 Generics -- 2.2.1.2.4 All Prescribed Drugs -- 2.2.2 UNITED STATES -- 2.2.2.1 Policies -- 2.2.2.2 US Price Studies -- 2.2.2.2.1 Generics -- 2.2.3 CONCLUSION -- REFERENCES -- 2.3 - Medicine Prices in Asia-Pacific Countries -- LIST OF ABBREVIATIONS -- 2.3.1 INTRODUCTION -- 2.3.2 PRICE STUDIES FOR SPECIFIC MEDICINES GROUPS -- 2.3.2.1 High-Cost Medicines -- 2.3.2.2 Medicines for Cancer -- 2.3.2.3 Medicines for Central Nervous System-Related Diseases.
2.3.2.4 Medicines for Hepatitis C -- 2.3.2.5 Antiretroviral Medicines -- 2.3.2.6 Generic Medicines -- 2.3.3 CONCORDANCE OF PRICES WITH AFFORDABILITY -- 2.3.3.1 China (Upper Middle-Income Country) -- 2.3.3.2 Sri Lanka (Lower Middle-Income Country) -- 2.3.3.3 Malaysia (Upper Middle-Income Country) -- 2.3.4 IMPACT OF POLICY MEASURES -- 2.3.5 FINAL REMARKS -- REFERENCES -- 2.4 - Medicine Prices in Latin American Countries -- LIST OF ABBREVIATIONS -- 2.4.1 THE PRICE OF MEDICINES IN LATIN AMERICAN COUNTRIES -- 2.4.1.1 Introduction -- 2.4.1.2 Examples of Price Regulation in the Latin America Region -- 2.4.1.2.1 Colombian Medicines Pricing Regulation -- 2.4.1.2.2 Brazilian Medicines Pricing Regulation -- 2.4.1.2.3 Price Regulation in Other Latin American Countries -- 2.4.2 ONLINE SOURCES OF MEDICINES PRICES IN LATIN AMERICA -- 2.4.3 MEDICINE PRICE STUDIES IN LATIN AMERICAN COUNTRIES -- 2.4.3.1 Introduction -- 2.4.3.2 Methodology -- 2.4.3.3 Results and Findings -- 2.4.4 CONCLUSIONS -- REFERENCES -- FURTHER READING -- 2.5 - Medicine Prices in Africa -- LIST OF ABBREVIATIONS -- 2.5.1 INTRODUCTION -- 2.5.2 BACKGROUND TO HEALTH AND HEALTH SYSTEMS IN AFRICA -- 2.5.2.1 Growth in Sub-Saharan Africa -- 2.5.2.2 Health Care in Africa -- 2.5.2.3 Provision of Health Care in Africa -- 2.5.3 THE AFRICAN MEDICINES ENVIRONMENT -- 2.5.4 METHODS FOR SELECTING STUDIES ON PRICING AND AVAILABILITY -- 2.5.5 OVERVIEW OF FINDINGS -- 2.5.6 DISCUSSION ON MEDICINES AVAILABILITY AND PRICING IN AFRICA -- 2.5.6.1 Measurement of Availability of Medicines -- 2.5.6.2 Measurement of Availability and Price -- 2.5.6.3 Measurement of Pricing of Medicines -- 2.5.6.4 Multicountry Comparisons -- 2.5.7 CONCLUSIONS: SUMMARY AND WAY FORWARD -- 2.5.8 GAPS IN THE LITERATURE -- REFERENCES -- 3 - Price Studies for Specific Medicines -- LIST OF ABBREVIATIONS -- 3.1 GENERIC AND BIOSIMILAR MEDICINES. 3.2 HIGH-PRICED MEDICINES, INCLUDING ORPHAN MEDICINAL PRODUCTS -- 3.3 MEDICINES FOR SPECIFIC INDICATIONS -- 3.3.1 HIV/AIDS Medicines -- 3.3.2 Cancer Medicines -- 3.3.3 Hepatitis C Medicines -- 3.3.4 Further Indications -- 3.4 HOSPITAL MEDICINES -- 3.5 NON-PRESCRIPTION MEDICINES -- 3.6 CONCLUSION -- REFERENCES -- 4 - Studies of Medicine Price Developments -- LIST OF ABBREVIATIONS -- 4.1 IMPACT ASSESSMENT -- 4.2 NATIONAL STUDIES -- 4.3 CROSS-NATIONAL STUDIES -- REFERENCES -- 5 - Discussion and Summary -- LIST OF ABBREVIATIONS -- REFERENCES -- 2 - Training - How to Conduct Medicine Price Surveys, Analyses and Comparisons? -- 6 - Review of Methodologies to Conduct Price Studies -- LIST OF ABBREVIATIONS -- 6.1 - Overview of Existing Methodologies -- 6.2 - WHO/HAI Methodology for Measuring Medicine Prices, Availability and Affordability, and Price Components -- 6.2.1 BACKGROUND AND HISTORY -- 6.2.2 OBJECTIVE OF THE WORLD HEALTH ORGANIZATION/HEALTH ACTION INTERNATIONAL METHODOLOGY -- 6.2.3 STEPS OF A SURVEY USING THE WORLD HEALTH ORGANIZATION/HEALTH ACTION INTERNATIONAL METHODOLOGY -- 6.2.3.1 Presurvey Planning -- 6.2.3.2 Preparation of the Survey -- 6.2.3.3 Training of Area Supervisors, Data Collectors, and Data Entry Personnel -- 6.2.3.4 Preparing for Data Collection -- 6.2.3.5 Data Collection in the Field -- 6.2.3.6 Data Entry -- 6.2.3.7 Data Analysis and Interpretation -- 6.2.3.7.1 Availability -- 6.2.3.7.2 Prices -- 6.2.3.7.3 Affordability -- 6.2.3.8 Measuring Price Components -- 6.2.3.9 International Comparisons of Data from Surveys Undertaken Using the World Health Organization/Health Action International Methodology -- 6.2.3.10 Exploring Policy Options -- 6.2.3.11 Reporting -- 6.2.4 USE OF THE WORLD HEALTH ORGANIZATION/HEALTH ACTION INTERNATIONAL METHODOLOGY IN PRACTICE -- REFERENCES. 7 - Terminology - Is Talking About Definitions Boring, or Is It the Starting Point? -- LIST OF ABBREVIATIONS -- 7.1 PURPOSE -- 7.2 KEY TERMS -- 7.3 TRAINING MATERIAL: EXERCISES -- 7.3.1 Definitions - Multiple Choice Questions -- 7.3.2 Cloze test - Please Fill Out This Cloze Test by Adding the Missing Words -- 7.3.3 Crossword Puzzle -- REFERENCES -- 8 - Medicine Price Data Sources -- LIST OF ABBREVIATIONS -- 8.1 SELECTION OF MEDICINE PRICE DATA SOURCES -- 8.1.1 Taxonomy of Data Sources -- 8.1.2 Assessment of Data Sources -- 8.2 MEDICINE PRICE SERVICES AND DATABASES -- 8.2.1 Public Sector Data Sources -- 8.2.2 Collaborative Initiatives -- 8.2.2.1 Management Sciences for Health -- 8.2.2.2 Early Advances in Europe: European Commission's Projects -- 8.2.2.3 EURopean Integrated Price Information Database (Euripid) -- 8.2.2.4 Decisiones Informadas en Medicamentos Platform in Latin America -- 8.2.2.5 Western Pacific Platform for Procurement Prices -- 8.2.2.6 WHO Global Price Reporting Mechanism for HIV, Tuberculosis, and Malaria -- 8.2.2.7 Vaccine Product, Price, and Procurement Platform -- 8.2.3 Other Providers -- REFERENCES -- 9 - Preparing Price Studies - Key Methodological Decisions -- LIST OF ABBREVIATIONS -- 9.1 INTRODUCTION -- 9.2 PURPOSE AND PERSPECTIVE -- 9.3 KEY METHODOLOGICAL DECISIONS -- 9.3.1 Geographic Area -- 9.3.2 Sectors and Settings -- 9.3.3 Medicines -- 9.3.4 Price Data -- 9.3.4.1 Definitions of Medicine Price and `Price Proxies' -- 9.3.4.2 Units of Measurement -- 9.3.4.3 Price Types -- 9.3.4.3.1 Price Components along the Supply Chain -- 9.3.4.3.2 Reimbursement Prices -- 9.3.4.3.3 List Prices and Confidentiality -- 9.3.5 Time Period -- 9.3.5.1 Cross-sectional Studies -- 9.3.5.2 Time-Series Analyses -- 9.3.6 Specific Decisions Related to Cross-Country Comparisons -- 9.3.6.1 Comparator Countries -- 9.3.6.2 Comparable Medicines. 9.3.6.2.1 Strategies to Optimise Medicine Selection for Cross-Country Comparison -- 9.3.6.2.2 Like-for-Like Comparison -- 9.3.6.3 Comparable Price Types -- 9.3.6.4 Weighting for Volume (Price Indices) -- 9.3.6.5 Choice of Conversion Rate and Weighting for Income -- 9.4 LIMITATIONS AND CONCLUSIONS -- REFERENCES -- 10 - Training Exercises for Medicine Price Surveys, Analyses and Comparisons -- LIST OF ABBREVIATIONS -- 10.1 PURPOSE -- 10.2 TRAINING MATERIAL: EXERCISES -- 10.2.1 Exercise 1 - Preparation of the Study (Methodology) -- 10.2.2 Exercise 2 - Price Data Calculation -- 10.2.2.1 Q1: One of the Top-Selling Products Is Glupic -- 10.2.3 Exercise 3 - Price Data Presentation and Data Analysis -- 10.2.3.1 Q1: Price Differences to the Neighbouring Countries -- 10.2.3.2 Q2: Index Calculation -- 10.2.3.3 Q3: Box Plot Data Presentation -- 10.2.3.4 Q4: Prices in Purchasing Power Parities (PPP) -- REFERENCES -- 3 - Using Medicine Price Comparisons for Policy-Making -- 11 - Price Comparison as a Pricing Policy Option-Introduction into Pharmaceutical Policies -- LIST OF ABBREVIATIONS -- 11.1 NEED FOR PHARMACEUTICAL REGULATION AND POLICIES -- 11.1.1 Regulation-to Ensure Safety of Medicines and Pharmaceutical Provision -- 11.1.2 Pharmaceutical Policies-to Contribute to Affordable Access to Medicines -- 11.2 TAXONOMIES OF PHARMACEUTICAL POLICIES -- 11.3 INTRODUCTION INTO PRICING POLICIES -- 11.3.1 Medicines Groups -- 11.3.2 Sectors -- 11.3.3 Price Types -- REFERENCES -- 12 - Practice of External Price Referencing -- LIST OF ABBREVIATIONS -- 12.1 OVERVIEW OF USE OF EPR WORLDWIDE -- 12.1.1 Relevance of EPR -- 12.1.2 Reference Countries -- 12.1.3 Scope of Medicines -- 12.1.4 Price Types -- 12.1.5 Calculation Method -- 12.2 OVERVIEW OF USE OF EPR IN WHO EURO REGION -- 12.2.1 Relevance of EPR -- 12.2.2 Reference Countries -- 12.2.3 Scope of Medicines. 12.2.4 Price Types. |
| Record Nr. | UNINA-9910583013503321 |
| London, England : , : Elsevier, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pay-for-delay [[electronic resource] ] : how drug company pay-offs cost consumers billions : an FTC staff study
| Pay-for-delay [[electronic resource] ] : how drug company pay-offs cost consumers billions : an FTC staff study |
| Pubbl/distr/stampa | Washington, DC : , : U.S. Federal Trade Commission, , 2010 |
| Descrizione fisica | 1 online resource (12 pages) : color illustrations |
| Soggetto topico |
Pharmaceutical industry - Corrupt practices - United States
Prescription pricing - United States Drugs - Prices |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pay-for-delay |
| Record Nr. | UNINA-9910696951903321 |
| Washington, DC : , : U.S. Federal Trade Commission, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Prescription drug pricing in the private sector [[electronic resource]]
| Prescription drug pricing in the private sector [[electronic resource]] |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Congress of the U.S., Congressional Budget Office, , [2007] |
| Descrizione fisica | vii, 26 pages : digital, PDF file |
| Collana | A CBO paper |
| Soggetto topico |
Pharmaceutical industry
Pharmaceutical industry - United States Drugs - Prices |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910698229103321 |
| [Washington, D.C.] : , : Congress of the U.S., Congressional Budget Office, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Prescription drugs [[electronic resource] ] : an overview of approaches to negotiate drug prices used by other countries and U.S. private payers and federal programs : testimony before the Committee on Finance, U.S. Senate / / statement of John E. Dicken
| Prescription drugs [[electronic resource] ] : an overview of approaches to negotiate drug prices used by other countries and U.S. private payers and federal programs : testimony before the Committee on Finance, U.S. Senate / / statement of John E. Dicken |
| Autore | Dicken John E |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Government Accountability Office, , [2007] |
| Descrizione fisica | 17 pages : digital, PDF file |
| Collana | Testimony |
| Soggetto topico |
Drugs - Prices
Negotiation - Methodology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Prescription drugs |
| Record Nr. | UNINA-9910695791203321 |
Dicken John E
|
||
| [Washington, D.C.] : , : U.S. Government Accountability Office, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office)
| Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office) |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U. S. Government Publishing Office], , 2020- |
| Descrizione fisica | 1 online resource (volumes) |
| Collana | Rept. / 116th Congress, 2d session, House of Representatives |
| Soggetto topico |
Generic drugs - United States
Drugs - Prices - United States Prescription pricing - Law and legislation - United States Competition Drugs - Prices Generic drugs Prescription pricing - Law and legislation |
| Soggetto genere / forma | Legislative materials. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Preserve Access to Affordable Generics and Biosimilars Act |
| Record Nr. | UNINA-9910715395503321 |
| [Washington, D.C.] : , : [U. S. Government Publishing Office], , 2020- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The reality of medicine prices in Malaysia / / Zaheer-ud-din Babar [and three others]
| The reality of medicine prices in Malaysia / / Zaheer-ud-din Babar [and three others] |
| Autore | Babar Zaheer-ud-din |
| Pubbl/distr/stampa | Pulau Pinang, Malaysia : , : Penerbit Universiti Sains Malaysia, , [2010] |
| Descrizione fisica | 1 online resource (xiv, 116 pages) : illustrations |
| Disciplina | 338.436151 |
| Altri autori (Persone) | BabarZaheer-ud-din |
| Collana | Monograph series / Penerbit USM |
| Soggetto topico |
Drugs - Prices
Drugs - Prices - Malaysia Prescription pricing - Malaysia |
| ISBN | 967-461-090-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910792872903321 |
|
Babar Zaheer-ud-din
|
||
| Pulau Pinang, Malaysia : , : Penerbit Universiti Sains Malaysia, , [2010] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The reality of medicine prices in Malaysia / / Zaheer-ud-din Babar [and three others]
| The reality of medicine prices in Malaysia / / Zaheer-ud-din Babar [and three others] |
| Autore | Babar Zaheer-ud-din |
| Pubbl/distr/stampa | Pulau Pinang, Malaysia : , : Penerbit Universiti Sains Malaysia, , [2010] |
| Descrizione fisica | 1 online resource (xiv, 116 pages) : illustrations |
| Disciplina | 338.436151 |
| Altri autori (Persone) | BabarZaheer-ud-din |
| Collana | Monograph series / Penerbit USM |
| Soggetto topico |
Drugs - Prices
Drugs - Prices - Malaysia Prescription pricing - Malaysia |
| ISBN | 967-461-090-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910816858403321 |
|
Babar Zaheer-ud-din
|
||
| Pulau Pinang, Malaysia : , : Penerbit Universiti Sains Malaysia, , [2010] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Replacing average wholesale price : Medicaid drug payment policy
| Replacing average wholesale price : Medicaid drug payment policy |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011 |
| Descrizione fisica | 1 online resource (iv, 19 pages) |
| Soggetto topico |
Medicaid
Prescription pricing - United States Drugs - Prices - United States Pharmaceutical services insurance - United States Pharmaceutical policy - United States Drugs - Prices Pharmaceutical policy Pharmaceutical services insurance Prescription pricing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Replacing average wholesale price |
| Record Nr. | UNINA-9910707233403321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ryan White Care Act [[electronic resource] ] : impact of legislative funding proposal on urban areas
| Ryan White Care Act [[electronic resource] ] : impact of legislative funding proposal on urban areas |
| Autore | Crosse Marcia |
| Pubbl/distr/stampa | Washington, DC : , : U.S. Govt. Accountability Office, , [2007] |
| Descrizione fisica | 18 pages : digital, PDF file |
| Soggetto topico |
Drugs - Prices
AIDS (Disease) - United States - Prevention - Finance |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Ryan White Care Act |
| Record Nr. | UNINA-9910698363103321 |
|
Crosse Marcia
|
||
| Washington, DC : , : U.S. Govt. Accountability Office, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ryan White Care Act [[electronic resource] ] : improved oversight needed to ensure AIDS drug assistance programs obtain best prices for drugs : report to congressional requesters
| Ryan White Care Act [[electronic resource] ] : improved oversight needed to ensure AIDS drug assistance programs obtain best prices for drugs : report to congressional requesters |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Government Accountability Office, , [2006] |
| Descrizione fisica | iii, 67 pages : digital, PDF file |
| Soggetto topico |
Drugs - Prices
AIDS (Disease) - United States - Prevention - Finance |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Ryan White Care Act |
| Record Nr. | UNINA-9910695139903321 |
| [Washington, D.C.] : , : U.S. Government Accountability Office, , [2006] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
